Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0065 USD
−13.19 M USD
6.88 M USD
1.72 B
About IMPEDIMED LIMITED
Sector
Industry
CEO
Parmjot Bains
Website
Headquarters
Pinkenba
Founded
1999
ISIN
AU000000IPD8
FIGI
BBG000PM3278
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IPDQF is 0.0483 USD — it has increased by 43.32% in the past 24 hours. Watch Impedimed Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Impedimed Ltd stocks are traded under the ticker IPDQF.
IPDQF stock has risen by 40.41% compared to the previous week, the month change is a −21.84% fall, over the last year Impedimed Ltd has showed a −46.33% decrease.
We've gathered analysts' opinions on Impedimed Ltd future price: according to them, IPDQF price has a max estimate of 0.12 USD and a min estimate of 0.06 USD. Watch IPDQF chart and read a more detailed Impedimed Ltd stock forecast: see what analysts think of Impedimed Ltd and suggest that you do with its stocks.
IPDQF reached its all-time high on Aug 12, 2016 with the price of 1.3800 USD, and its all-time low was 0.0220 USD and was reached on May 7, 2020. View more price dynamics on IPDQF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IPDQF stock is 30.23% volatile and has beta coefficient of 0.77. Track Impedimed Ltd stock price on the chart and check out the list of the most volatile stocks — is Impedimed Ltd there?
Today Impedimed Ltd has the market capitalization of 72.44 M, it has decreased by −1.18% over the last week.
Yes, you can track Impedimed Ltd financials in yearly and quarterly reports right on TradingView.
Impedimed Ltd is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
IPDQF earnings for the last half-year are 0.00 USD per share, whereas the estimation was 0.00 USD, resulting in a 16.67% surprise. The estimated earnings for the next half-year are 0.00 USD per share. See more details about Impedimed Ltd earnings.
Impedimed Ltd revenue for the last half-year amounts to 4.23 M USD, despite the estimated figure of 3.67 M USD. In the next half-year revenue is expected to reach 5.01 M USD.
IPDQF net income for the last half-year is −6.71 M USD, while the previous report showed −6.62 M USD of net income which accounts for −1.48% change. Track more Impedimed Ltd financial stats to get the full picture.
No, IPDQF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 83.00 employees. See our rating of the largest employees — is Impedimed Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Impedimed Ltd EBITDA is −14.27 M USD, and current EBITDA margin is −210.50%. See more stats in Impedimed Ltd financial statements.
Like other stocks, IPDQF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Impedimed Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Impedimed Ltd technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Impedimed Ltd stock shows the sell signal. See more of Impedimed Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.